Nexgel Inc (NXGL)

$0.61 -0.04 (-5.60%)
Market Cap 6.31M
Revenue (ttm) 11.42M
Net Income (ttm) -3.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -26.27%
Debt to Equity Ratio 0.00
Volume 179,418
Avg Vol 430,186
Day's Range N/A - N/A
Shares Out 8.48M
Stochastic %K 29%
Beta 0.85
Analysts Strong Sell
Price Target $2.00

Company Profile

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin;...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 215 702 8550
Website: nexgel.com
Address:
2150 Cabot Boulevard West, Suite B, Langhorne, United States
BambooBun
BambooBun Apr. 22 at 9:27 PM
$NXGL
0 · Reply
Combat_Vet
Combat_Vet Apr. 22 at 3:41 PM
$NXGL That earnings report was a disaster
0 · Reply
Dizzy8
Dizzy8 Apr. 22 at 11:05 AM
$NXGL Why sell now at this low a price? a) You like loosing money. b) You like the next guy to have a lot of money. c) You hate money
0 · Reply
luckydog2
luckydog2 Apr. 22 at 12:42 AM
$CELU $NXGL https://www.reddit.com/r/CelularityNews/s/tWSVj7E8Lr
0 · Reply
TolucaBlake
TolucaBlake Apr. 21 at 10:42 PM
$NXGL call was bullish but I found it odd that Adam kept talking about how great it will be to have the sales team they are getting in this acquisition. It is a positive but how exactly were they even trying to sell products before with no sales team?
1 · Reply
Gymlover
Gymlover Apr. 21 at 8:59 PM
$NXGL
0 · Reply
Tracey11
Tracey11 Apr. 21 at 8:05 PM
$NXGL 🤞
0 · Reply
endrow
endrow Apr. 21 at 4:43 PM
$NXGL Finally some good news, I hope that the conference call will also go well!
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 21 at 4:38 PM
$NXGL
0 · Reply
Bigmal1
Bigmal1 Apr. 21 at 4:34 PM
$NXGL it broke out!!
0 · Reply
Latest News on NXGL
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

Apr 17, 2026, 3:37 PM EDT - 6 days ago

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction

Apr 15, 2026, 4:12 PM EDT - 8 days ago

NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction

NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction

Apr 8, 2026, 4:05 PM EDT - 15 days ago

NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction

NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity

Mar 31, 2026, 4:12 PM EDT - 23 days ago

NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity

NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products

Mar 12, 2026, 8:45 AM EDT - 6 weeks ago

NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products

NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

Mar 10, 2026, 8:45 AM EDT - 6 weeks ago

NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue

Mar 10, 2026, 8:30 AM EDT - 6 weeks ago

EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue

CELU

NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

Dec 11, 2025, 8:00 AM EST - 4 months ago

NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

NEXGEL Reports Third Quarter 2025 Financial Results

Nov 11, 2025, 4:10 PM EST - 5 months ago

NEXGEL Reports Third Quarter 2025 Financial Results

NEXGEL to Report Second Quarter 2025 Financial Results on August 12th

Aug 6, 2025, 8:00 AM EDT - 9 months ago

NEXGEL to Report Second Quarter 2025 Financial Results on August 12th

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement

Aug 1, 2025, 8:00 AM EDT - 9 months ago

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement

NEXGEL and STADA AG Announce Expansion of Partnership for North America

Jul 14, 2025, 9:00 AM EDT - 10 months ago

NEXGEL and STADA AG Announce Expansion of Partnership for North America

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

May 9, 2025, 9:00 AM EDT - 1 year ago

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

Mar 24, 2025, 4:05 PM EDT - 1 year ago

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

Mar 19, 2025, 9:00 AM EDT - 1 year ago

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

Feb 13, 2025, 9:00 AM EST - 1 year ago

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

Jan 2, 2025, 9:00 AM EST - 1 year ago

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

Nov 13, 2024, 4:40 PM EST - 1 year ago

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

NEXGEL Announces $2,000,000 Registered Direct Offering

Nov 11, 2024, 5:35 PM EST - 1 year ago

NEXGEL Announces $2,000,000 Registered Direct Offering

NEXGEL to Participate in Upcoming October Investor Conferences

Oct 11, 2024, 9:00 AM EDT - 1 year ago

NEXGEL to Participate in Upcoming October Investor Conferences

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

Oct 4, 2024, 9:00 AM EDT - 1 year ago

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million

Aug 14, 2024, 4:25 PM EDT - 1 year ago

NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

Aug 12, 2024, 9:15 AM EDT - 1 year ago

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

Jul 18, 2024, 9:15 AM EDT - 1 year ago

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

Jul 8, 2024, 4:05 PM EDT - 1 year ago

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

Jun 11, 2024, 8:40 AM EDT - 2 years ago

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

NEXGEL Acquires International Beauty Brand, Silly George

May 16, 2024, 9:00 AM EDT - 2 years ago

NEXGEL Acquires International Beauty Brand, Silly George

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

Apr 1, 2024, 7:50 AM EDT - 2 years ago

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

Mar 21, 2024, 9:00 AM EDT - 2 years ago

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

Mar 4, 2024, 8:30 AM EST - 2 years ago

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

Jan 9, 2024, 8:30 AM EST - 2 years ago

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

Dec 11, 2023, 8:00 AM EST - 2 years ago

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

Nov 13, 2023, 4:05 PM EST - 2 years ago

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd

Sep 26, 2023, 9:49 AM EDT - 2 years ago

NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

Aug 2, 2023, 9:00 AM EDT - 2 years ago

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America

Jul 19, 2023, 9:10 AM EDT - 3 years ago

NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America

NEXGEL to Participate in Maxim Group's Virtual Healthcare Conference on June 20th

Jun 15, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Participate in Maxim Group's Virtual Healthcare Conference on June 20th

NEXGEL to Participate in the LD Micro Invitational XIII on June 6th

May 24, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Participate in the LD Micro Invitational XIII on June 6th

NEXGEL to Report First Quarter 2023 Financial Results on May 15th

May 9, 2023, 9:15 AM EDT - 3 years ago

NEXGEL to Report First Quarter 2023 Financial Results on May 15th

NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 27, 2023, 4:05 PM EDT - 3 years ago

NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

Mar 15, 2023, 7:30 AM EDT - 3 years ago

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

Mar 7, 2023, 7:30 AM EST - 3 years ago

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business

Mar 2, 2023, 8:30 AM EST - 3 years ago

NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

Jan 17, 2023, 7:30 AM EST - 3 years ago

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

Dec 8, 2022, 7:30 AM EST - 3 years ago

NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

NEXGEL Announces Share Repurchase Program

Dec 7, 2022, 7:30 AM EST - 3 years ago

NEXGEL Announces Share Repurchase Program

NEXGEL to Host Fireside Chat with CEO Adam Levy on December 14th at 11:00 a.m. ET

Dec 1, 2022, 11:00 AM EST - 3 years ago

NEXGEL to Host Fireside Chat with CEO Adam Levy on December 14th at 11:00 a.m. ET

NEXGEL Reports Third Quarter 2022 Financial Results

Nov 8, 2022, 4:11 PM EST - 3 years ago

NEXGEL Reports Third Quarter 2022 Financial Results

NEXGEL to Report Third Quarter 2022 Financial Results on November 8th

Nov 2, 2022, 9:00 AM EDT - 3 years ago

NEXGEL to Report Third Quarter 2022 Financial Results on November 8th

BambooBun
BambooBun Apr. 22 at 9:27 PM
$NXGL
0 · Reply
Combat_Vet
Combat_Vet Apr. 22 at 3:41 PM
$NXGL That earnings report was a disaster
0 · Reply
Dizzy8
Dizzy8 Apr. 22 at 11:05 AM
$NXGL Why sell now at this low a price? a) You like loosing money. b) You like the next guy to have a lot of money. c) You hate money
0 · Reply
luckydog2
luckydog2 Apr. 22 at 12:42 AM
$CELU $NXGL https://www.reddit.com/r/CelularityNews/s/tWSVj7E8Lr
0 · Reply
TolucaBlake
TolucaBlake Apr. 21 at 10:42 PM
$NXGL call was bullish but I found it odd that Adam kept talking about how great it will be to have the sales team they are getting in this acquisition. It is a positive but how exactly were they even trying to sell products before with no sales team?
1 · Reply
Gymlover
Gymlover Apr. 21 at 8:59 PM
$NXGL
0 · Reply
Tracey11
Tracey11 Apr. 21 at 8:05 PM
$NXGL 🤞
0 · Reply
endrow
endrow Apr. 21 at 4:43 PM
$NXGL Finally some good news, I hope that the conference call will also go well!
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 21 at 4:38 PM
$NXGL
0 · Reply
Bigmal1
Bigmal1 Apr. 21 at 4:34 PM
$NXGL it broke out!!
0 · Reply
Bigmal1
Bigmal1 Apr. 21 at 3:39 PM
$NXGL this is trading in such a tight sideways pattern today
0 · Reply
Ozcorp
Ozcorp Apr. 21 at 2:47 PM
$NXGL pushhhh
0 · Reply
Bakhm
Bakhm Apr. 21 at 2:33 PM
$NXGL .90 today?
0 · Reply
Bakhm
Bakhm Apr. 21 at 1:56 PM
$NXGL wtf
0 · Reply
Combat_Vet
Combat_Vet Apr. 21 at 1:55 PM
$NXGL Burn the shorts
0 · Reply
SelfishPotato
SelfishPotato Apr. 21 at 1:44 PM
$NXGL what an amazing stock Same growth as $CRDO
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Apr. 21 at 1:40 PM
$NXGL Another beautiful day.. This bag is gone and we have 41 straight overnight swing winners ... $.86 high and may not be done 😋😋😋😋
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Apr. 21 at 1:17 PM
$NXGL Closes acquisition and expects revenue to triple... Theres no way this can't see $1.00 imo.. $.63 major support and the 50 is at $.91 🚨🚨🚨🚨
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 21 at 1:12 PM
$NXGL NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
0 · Reply
luckydog2
luckydog2 Apr. 21 at 1:09 PM
$CELU $NXGL NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment https://www.globenewswire.com/news-release/2026/04/21/3278047/0/en/nexgel-new-strategic-partner-sequence-lifescience-leads-financing-with-5-5-million-to-complete-acquisition-of-celularity-degenerative-disease-segment.html?_gl=1*1cwoopb*_up*MQ..*_ga*MzQxNDYwMDM0LjE3NzY3NzY4NjM.*_ga_B6167QB2TF*czE3NzY3NzY4NjIkbzEkZzAkdDE3NzY3NzY4NjIkajYwJGwwJGgw*_ga_ERWPGTJ5X8*czE3NzY3NzY4NjIkbzEkZzAkdDE3NzY3NzY4NjIkajYwJGwwJGgw
0 · Reply
SwingAll
SwingAll Apr. 20 at 7:43 PM
$NXGL it will spike tomorrow
0 · Reply
luckydog2
luckydog2 Apr. 18 at 1:12 AM
$CELU It appears as though $NXGL has secured the funding to purchase $CELU biomaterials. https://www.globenewswire.com/news-release/2026/04/17/3276466/0/en/nexgel-moves-forward-shareholder-update-call-to-discuss-celularity-transaction-on-april-21st-at-4-30-p-m-et.html?_gl=1*bjff6w*_up*MQ..*_ga*MjE0MDU2MDY3OC4xNzc2NDczNDA0*_ga_B6167QB2TF*czE3NzY0NzM0MDQkbzEkZzAkdDE3NzY0NzM0MDQkajYwJGwwJGgw*_ga_ERWPGTJ5X8*czE3NzY0NzM0MDQkbzEkZzAkdDE3NzY0NzM0MDQkajYwJGwwJGgw
1 · Reply